Last week, Bastian Voice Institute treated our first patient with Papzimeos, a new, FDA approved medication for laryngeal papillomatosis, aka recurrent respiratory papillomatosis (RRP). For the majority of patients, this first-of-its-kind medication greatly reduces, if not eliminates, the need for repeated surgeries to treat this condition.
BVI is pleased to be among the first facilities to offer a new treatment that holds such promise for our large caseload of patients with this HPV-related disease!